Detalhe da pesquisa
1.
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up.
Clin Infect Dis
; 78(1): 164-171, 2024 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37773767
2.
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
Clin Infect Dis
; 78(1): 144-148, 2024 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37606512
3.
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Am J Respir Crit Care Med
; 207(11): 1525-1532, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36802336
4.
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Clin Infect Dis
; 75(6): 1006-1013, 2022 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35028659
5.
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
Clin Infect Dis
; 75(8): 1307-1314, 2022 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35243494
6.
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings.
Eur Respir J
; 59(1)2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34140298
7.
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 71(2): 415-418, 2020 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31676905
8.
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
Emerg Infect Dis
; 25(5): 936-943, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31002070
9.
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.
BMC Infect Dis
; 19(1): 733, 2019 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31429722
10.
Corrigendum to 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients' [J Hepatol 72 (2020) 1028-1029].
J Hepatol
; 77(2): 583, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35581037
11.
The Reductionist Conundrum of an "Updated" Definition of Extensively Drug-Resistant Tuberculosis.
Am J Respir Crit Care Med
; 204(6): 629-631, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34375572
12.
High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients.
J Hepatol
; 72(5): 1028-1029, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32147086
13.
Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?
Am J Respir Crit Care Med
; 198(9): 1228-1231, 2018 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29969054
14.
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
Nat Commun
; 15(1): 3927, 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38724531
15.
Effectiveness of a bedaquiline, linezolid, clofazimine "core" for multidrug-resistant tuberculosis.
medRxiv
; 2024 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38293100
16.
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study.
Lancet Glob Health
; 11(1): e126-e135, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36521944
17.
Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up.
medRxiv
; 2023 May 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37398252
18.
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective.
PLOS Glob Public Health
; 3(4): e0000818, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37115740
19.
Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods study.
J Clin Tuberc Other Mycobact Dis
; 27: 100316, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35521634
20.
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.
Eur Respir J
; 48(3): 938-43, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27338197